BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 19116938)

  • 81. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.
    Månsson B; Carey D; Alini M; Ionescu M; Rosenberg LC; Poole AR; Heinegård D; Saxne T
    J Clin Invest; 1995 Mar; 95(3):1071-7. PubMed ID: 7533784
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
    Dam EB; Byrjalsen I; Karsdal MA; Qvist P; Christiansen C
    Osteoarthritis Cartilage; 2009 Mar; 17(3):384-9. PubMed ID: 18768336
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.
    Conrozier T; Poole AR; Ferrand F; Mathieu P; Vincent F; Piperno M; Verret C; Ionescu M; Vignon E
    Clin Exp Rheumatol; 2008; 26(3):430-5. PubMed ID: 18578964
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases.
    Oestergaard S; Chouinard L; Doyle N; Karsdal MA; Smith SY; Qvist P; Tankó LB
    Osteoarthritis Cartilage; 2006 Jul; 14(7):670-9. PubMed ID: 16500121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score.
    Melchiorre D; Linari S; Innocenti M; Biscoglio I; Toigo M; Cerinic MM; Morfini M
    Haemophilia; 2011 Jan; 17(1):112-7. PubMed ID: 21070482
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.
    Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis.
    Rodríguez-Merchán EC
    Clin Orthop Relat Res; 1997 Oct; (343):6-11. PubMed ID: 9345198
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Urine cartilage oligomeric matrix protein (COMP) measurement is useful in discriminating the osteoarthritic Thoroughbreds.
    Misumi K; Tagami M; Kamimura T; Miyakoshi D; Helal IE; Arai K; Fujiki M
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1174-80. PubMed ID: 16895759
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.
    Andersson ML; Petersson IF; Karlsson KE; Jonsson EN; Månsson B; Heinegård D; Saxne T
    Ann Rheum Dis; 2006 Nov; 65(11):1490-4. PubMed ID: 16707535
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of exercise on serum concentration of cartilage oligomeric matrix protein in Thoroughbreds.
    Helal IE; Misumi K; Tateno O; Kodama T; Ishimaru M; Yamamoto J; Miyakoshi D; Fujiki M
    Am J Vet Res; 2007 Feb; 68(2):134-40. PubMed ID: 17269877
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serum keratan sulfate is a promising marker of early articular cartilage breakdown.
    Wakitani S; Nawata M; Kawaguchi A; Okabe T; Takaoka K; Tsuchiya T; Nakaoka R; Masuda H; Miyazaki K
    Rheumatology (Oxford); 2007 Nov; 46(11):1652-6. PubMed ID: 17855425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis.
    Ben Achour W; Bouaziz M; Mechri M; Zouari B; Bahlous A; Abdelmoula L; Laadhar L; Sellami M; Sahli H; Cheour E
    Libyan J Med; 2018 Dec; 13(1):1512330. PubMed ID: 30160204
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Type II collagen markers in osteoarthritis: what do they indicate?
    Henrotin Y; Addison S; Kraus V; Deberg M
    Curr Opin Rheumatol; 2007 Sep; 19(5):444-50. PubMed ID: 17762609
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis.
    Hao HQ; Zhang JF; He QQ; Wang Z
    Osteoarthritis Cartilage; 2019 May; 27(5):726-736. PubMed ID: 30391538
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies.
    Conrozier T; Ferrand F; Poole AR; Verret C; Mathieu P; Ionescu M; Vincent F; Piperno M; Spiegel A; Vignon E
    Osteoarthritis Cartilage; 2007 Apr; 15(4):462-7. PubMed ID: 17055306
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Investigation of cartilage degradation in patients with spinal cord injury by CTX-II.
    Findikoglu G; Gunduz B; Uzun H; Erhan B; Rota S; Ardic F
    Spinal Cord; 2012 Feb; 50(2):136-40. PubMed ID: 21931328
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.
    Aurich M; Mwale F; Reiner A; Mollenhauer JA; Anders JO; Fuhrmann RA; Kuettner KE; Poole AR; Cole AA
    Arthritis Rheum; 2006 Jan; 54(1):244-52. PubMed ID: 16388531
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
    Valentino LA
    J Thromb Haemost; 2010 Sep; 8(9):1895-902. PubMed ID: 20586922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.